Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials

BACKGROUND: Chlorpromazine (CPZ) remains one of the most common drugs used for people with schizophrenia worldwide, and a benchmark against which other treatments can be evaluated. Quantitative reviews are rare; this one evaluates the effects of chlorpromazine in the treatment of schizophrenia in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Clive Elliott, Rathbone, John, Thornley, Ben, Clarke, Mike, Borrill, Jo, Wahlbeck, Kristian, Awad, A George
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274318/
https://www.ncbi.nlm.nih.gov/pubmed/16229742
http://dx.doi.org/10.1186/1741-7015-3-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274318/
https://www.ncbi.nlm.nih.gov/pubmed/16229742
http://dx.doi.org/10.1186/1741-7015-3-15

Ejemplares similares